The month leading into the biggest food holiday of the year has been stressful for the 41.7 million Americans who rely on the Supplemental Nutrition Assistance Program (SNAP), formerly known as food ...

Vertex Pharmaceuticals Incorporated is downgraded from Buy to Hold due to mounting headwinds and pipeline uncertainties. Vertex faces pressure from potential U.S. drug pricing reforms and tariffs, ...

Your genes code for all your traits. Some genes are dominant and expressed if you receive a copy from one parent. Others are recessive and only apparent if you receive a copy from both parents. Genes ...

Vertex Pharmaceuticals (VRTX) plunged after Q2 earnings and is now down 21% over the past year. The company has historically had a strong R&D pipeline and has consistently been a winner, but the ...

CEO Sam Altman called a strange graph in its GPT-5 presentation a ‘mega chart screwup.’ CEO Sam Altman called a strange graph in its GPT-5 presentation a ‘mega chart screwup.’ is a senior reporter ...

Investors have multiple reasons to like AbbVie stock. Eli Lilly remains a top stock to buy and hold. Vertex Pharmaceuticals is moving quickly to expand its markets beyond cystic fibrosis. 10 stocks we ...

Investors have multiple reasons to like AbbVie stock. Eli Lilly remains a top stock to buy and hold. Vertex Pharmaceuticals is moving quickly to expand its markets beyond cystic fibrosis. The "it" ...

Users of certain advanced AI systems might have noticed their favorite model can remember their preferences regarding tone, formatting, prior topics of interest, how they like responses structured and ...

July 1 (Reuters) - Vertex Pharmaceuticals (VRTX.O), opens new tab said on Tuesday its next-generation cystic fibrosis treatment has won European Union approval for a rare and progressive genetic ...

Boston and London biotech company Vertex Pharmaceuticals is on a roll. In the past year and a half, Vertex worked with CRISPR Therapeutics to develop the first CRISPR treatment approved by the U.S.